If you are still having problems viewing this message, please click here for additional help.


Diagenode's epigenetics services - get better data, faster

DNA, RNA, and chromatin — integrative epigenomics profiling

  • DNA methylation analysis via RRBS
  • ChIP-Seq for low inputs, histones, transcription factors, other chromatin-associated proteins
  • RNA-seq for small RNAs, mRNA, ncRNAs, whole transcriptome using a ligation-free technology to detect picogram quantities of RNA, including bioinformatics analysis
Utilize our epigenetics expertise. We provide all wet lab and bioinformatics services using proprietary protocols designed to get you superior results.


Volume 37, Issue 28

In this issue
Also new


BRD4 facilitates replication stress-induced DNA damage response

Jingwen Zhang, Austin M. Dulak, Maureen M. Hattersley, Brandon S. Willis, Jenni Nikkilä et al.

Oncogene 2018 37 :3763 - 3777; April 11, 2018; 10.1038/s41388-018-0194-3

Abstract | Full Text

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway

Yu Yu, Yohan Suryo Rahmanto, Meng-Horng Lee, Pei-Hsun Wu, Jude M. Phillip et al.

Oncogene 2018 37 :3778 - 3789; April 11, 2018; 10.1038/s41388-018-0241-0

Abstract | Full Text

Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis

George Vaniotis, Roni F. Rayes, Shu Qi, Simon Milette, Ni Wang et al.

Oncogene 2018 37 :3790 - 3805; April 13, 2018; 10.1038/s41388-018-0242-z

Abstract | Full Text

Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins

Kalpana Deepa Priya Dorayappan, Ross Wanner, John J. Wallbillich, Uksha Saini, Roman Zingarelli et al.

Oncogene 2018 37 :3806 - 3821; April 11, 2018; 10.1038/s41388-018-0189-0

Abstract | Full Text

Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma

Zhonghu Li, Peng Jiang, Jie Li, Minjie Peng, Xin Zhao et al.

Oncogene 2018 37 :3822 - 3838; April 12, 2018; 10.1038/s41388-018-0237-9

Abstract | Full Text

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells

Marica Pinazza, Margherita Ghisi, Sonia Minuzzo, Valentina Agnusdei, Gianluca Fossati et al.

Oncogene 2018 37 :3839 - 3851; April 12, 2018; 10.1038/s41388-018-0234-z

Abstract | Full Text

AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells

Nicolas Coant, Mónica García-Barros, Qifeng Zhang, Lina M. Obeid & Yusuf A. Hannun

Oncogene 2018 37 :3852 - 3863; April 17, 2018; 10.1038/s41388-018-0236-x

Abstract | Full Text

MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function

Jinqiu Lu, Liansheng Liu, Mingjie Zheng, Xiaoling Li, Ailing Wu et al.

Oncogene 2018 37 :3864 - 3878; April 17, 2018; 10.1038/s41388-018-0249-5

Abstract | Full Text

The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L

A. L. Guarnieri, C. G. Towers, D. J. Drasin, M. U. J. Oliphant, Z. Andrysik et al.

Oncogene 2018 37 :3879 - 3893; April 17, 2018; 10.1038/s41388-018-0239-7

Abstract | Full Text

An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo

Koichi Tomoshige, Minzhe Guo, Tomoshi Tsuchiya, Takuya Fukazawa, Iris M. Fink-Baldauf et al.

Oncogene 2018 37 :3894 - 3908; April 17, 2018; 10.1038/s41388-018-0240-1

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature